All posts by NIRAMAI

Niramai wins at the 5th Commonwealth Digital Health Awards

We are happy to announce Niramai’s victory at the Commonwealth Digital Health Awards in the category of non-communicable diseases.

Niramai Health Analytix, India’s foremost and innovative AI-based breast cancer screening company has won the 5th Commonwealth Digital Health Awards in the category of non-communicable disease. 

The event celebrates digital innovations and encourages health and well-being transformation for individuals. The 5th edition of this event provided a launch pad for medical innovations to reach the next level amidst the new normal. The vision of the Commonwealth Center for Digital Health is that all Commonwealth nations should have affordable access to the benefits of Digital Health solutions and services. 

Niramai’s flagship product ‘Thermalytix’ uses a high-resolution thermal sensing device and a cloud-hosted analytics solution for analyzing thermal images using data analytics and artificial intelligence for reliable, early, and accurate breast cancer screening. NIRAMAI’s solution has led to 26 granted patents with 11 US patents and others across India, Singapore, China, and Canada. Niramai’s thermal screening facility is an experience that is non-invasive, painless, radiation-free, and generates screening reports immediately. The screening can be done any number of times and without any age restriction as it is radiation-free and can be used to detect lumps or abnormalities in the breast at an early stage. 


Dr. Geetha Manjunath, Founder & CEO, of Niramai, said,


“I am delighted to receive this Global Common Wealth Digital Health Award on behalf of NIRAMAI. We thank the organizing committee for creating this platform to showcase health tech innovation and the jury for recognizing the importance of our affordable, accessible, non-invasive privacy-aware method of screening for breast cancer. All the credits of this award goes to the passionate Niramai team who are consistently and persistently trying to solve this problem since the last 6 years. We thank our mentors, investors, and well-wishers for supporting us throughout this journey. Breast cancer is curable, so let us all work together to stop deaths caused due to it.”



Read More

Punjab partners with Niramai to become the 1st state to offer contactless breast cancer screening

June 14, 2022

Announcing our partnership with the Punjab Government in collaboration with Roche Pharma India

It is with great pride and honor that we announce Niramai’s partnership with the Punjab Government to contribute to women’s breast health awareness. 

It is with great pride and honor that we announce Niramai’s partnership with the Punjab Government to contribute to women’s breast health awareness. 

Niramai’s novel Artificial Intelligence-based, radiation-free, automated, non-invasive breast health screening test is called ThermalytixTM. It is a no-touch, no pain, a radiation-free privacy-sensitive screening test that detects breast cancer at an early stage for women of all age groups, whether symptomatic or asymptomatic.

The Punjab government advances the use of ThermalytixTM thus making Punjab the 1st state to offer contactless breast cancer screening and a joint initiative for the same has been commenced. The partnership named “Punjab Breast Cancer AI Digital project”, also known as the ‘Pink project’ is a collaboration among 3 operational institutions with distinctive allotted roles as follows:

  1. Niramai Health Analytix caters as the breast health screening partner
  2. Roche India contributes as a referral pathway technical partner
  3. And the Health Department, Govt. of Punjab is the initiator and fund supporter

This partnership project aims to accelerate breast health awareness through breast screening thus intending to downstage breast Cancer in the state of Punjab. It aids in increasing awareness towards early detection and management of breast cancer. 

Roche Products India Limited plays a vital role in this initiative and will act as a Technical Partner for project planning, implementation & monitoring of the state-wide Breast Cancer project plan, thereby strengthening the referral pathway through digitization. 

Early detection of Breast Cancer is extremely crucial to reduce mortality rates and provide appropriate treatment pathways on time. This approach intends on screening 15,000 women in a span of one year to accelerate the early-stage diagnosis of breast cancer. Since Niramai’s ThemalytixTM is a low-cost and portable breast screen test, it can be used as the primary screening method conducted by technicians with minimal training in resource-constrained locations as well. 

The Punjab government will ensure the mobilization of the population for screenings which would be supported by Niramai Health Analytix & Roche Pharma India. The Punjab screening camp commenced on 15th June 2022 and was inaugurated in presence of:

Director Family Welfare (DFW): Dr. Ranjit Singh Ghotra
Civil Surgeon, District Mohali: Dr. Adarshpal Kaur
Dr. Sandeep (State Programme Officer &Assistant Director, NPCDCS and His team.

Read More